HIV/AIDS

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Quick Look: Antiretroviral Price Increases in Medicare Part D

Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the federal government if prices increase faster than inflation. We assessed list price changes for ARVs under Part D, which is required to cover all or substantially all ARVs.

HIV, Intimate Partner Violence (IPV), and Women: An Emerging Policy Landscape

Intimate partner violence has been shown to be associated with increased risk for HIV among women, as well as poorer treatment outcomes for those already diagnosed. This brief reviews the link between IPV and HIV, key policy changes and initiatives that attempt to address these challenges.

Medicaid and HIV

This fact sheet provides an overview of the role of Medicaid for people with HIV, including trends and characteristics of beneficiaries, spending, services and other issues.

The Global HIV/AIDS Epidemic

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2018

This report, produced in partnership with UNAIDS, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to multilateral organizations. It provides the latest data available on donor funding disbursements based on data provided by governments, including their bilateral assistance to low- and middle-income countries and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria as well as UNIAID.